WHWK
Price
$1.80
Change
+$0.03 (+1.69%)
Updated
Aug 29 closing price
Capitalization
85.07M
64 days until earnings call
WXIBF
Price
$4.40
Change
+$0.20 (+4.76%)
Updated
Aug 26 closing price
Capitalization
17.25B
Interact to see
Advertisement

WHWK vs WXIBF

Header iconWHWK vs WXIBF Comparison
Open Charts WHWK vs WXIBFBanner chart's image
Whitehawk Therapeutics
Price$1.80
Change+$0.03 (+1.69%)
Volume$155.41K
Capitalization85.07M
Wuxi Biologics (Cayman)
Price$4.40
Change+$0.20 (+4.76%)
Volume$1.5K
Capitalization17.25B
WHWK vs WXIBF Comparison Chart in %
Loading...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
WHWK vs. WXIBF commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is WHWK is a Hold and WXIBF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (WHWK: $1.80 vs. WXIBF: $4.40)
Brand notoriety: WHWK and WXIBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: WHWK: 145% vs. WXIBF: 63%
Market capitalization -- WHWK: $85.07M vs. WXIBF: $17.25B
WHWK [@Biotechnology] is valued at $85.07M. WXIBF’s [@Biotechnology] market capitalization is $17.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

WHWK’s FA Score shows that 0 FA rating(s) are green whileWXIBF’s FA Score has 1 green FA rating(s).

  • WHWK’s FA Score: 0 green, 5 red.
  • WXIBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both WHWK and WXIBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WHWK’s TA Score shows that 4 TA indicator(s) are bullish while WXIBF’s TA Score has 4 bullish TA indicator(s).

  • WHWK’s TA Score: 4 bullish, 6 bearish.
  • WXIBF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, WXIBF is a better buy in the short-term than WHWK.

Price Growth

WHWK (@Biotechnology) experienced а +3.74% price change this week, while WXIBF (@Biotechnology) price change was +4.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.59%, and the average quarterly price growth was +30.71%.

Reported Earning Dates

WHWK is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($17.3B) has a higher market cap than WHWK($85.1M). WXIBF has higher P/E ratio than WHWK: WXIBF (32.12) vs WHWK (11.67). WXIBF YTD gains are higher at: 102.765 vs. WHWK (-42.789).
WHWKWXIBFWHWK / WXIBF
Capitalization85.1M17.3B0%
EBITDA-10.21MN/A-
Gain YTD-42.789102.765-42%
P/E Ratio11.6732.1236%
Revenue21.6MN/A-
Total Cash177MN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
WHWK vs WXIBF: Fundamental Ratings
WHWK
WXIBF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
9463
PRICE GROWTH RATING
1..100
6136
P/E GROWTH RATING
1..100
4510
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (37) in the Pharmaceuticals Major industry is in the same range as WXIBF (68) in the null industry. This means that WHWK’s stock grew similarly to WXIBF’s over the last 12 months.

WHWK's Profit vs Risk Rating (97) in the Pharmaceuticals Major industry is in the same range as WXIBF (100) in the null industry. This means that WHWK’s stock grew similarly to WXIBF’s over the last 12 months.

WXIBF's SMR Rating (63) in the null industry is in the same range as WHWK (94) in the Pharmaceuticals Major industry. This means that WXIBF’s stock grew similarly to WHWK’s over the last 12 months.

WXIBF's Price Growth Rating (36) in the null industry is in the same range as WHWK (61) in the Pharmaceuticals Major industry. This means that WXIBF’s stock grew similarly to WHWK’s over the last 12 months.

WXIBF's P/E Growth Rating (10) in the null industry is somewhat better than the same rating for WHWK (45) in the Pharmaceuticals Major industry. This means that WXIBF’s stock grew somewhat faster than WHWK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
WHWKWXIBF
RSI
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 5 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
67%
Momentum
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
68%
MACD
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
62%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 19 days ago
78%
Declines
ODDS (%)
Bearish Trend 19 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
62%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCNI1.530.07
+4.79%
Scinai Immunotherapeutics Ltd.
NTIC7.400.03
+0.34%
Northern Technologies International Corp
NXT67.26-0.85
-1.25%
Nextracker
PRTC17.07-0.28
-1.61%
PureTech Health plc
PSIX82.89-2.01
-2.37%
Power Solutions International Inc

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been closely correlated with ELVAF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if WHWK jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
+1.98%
ELVAF - WHWK
76%
Closely correlated
N/A
DMAC - WHWK
49%
Loosely correlated
-2.73%
TRAW - WHWK
39%
Loosely correlated
-1.41%
CLYYF - WHWK
37%
Loosely correlated
N/A
IDYA - WHWK
34%
Loosely correlated
-1.52%
More

WXIBF and

Correlation & Price change

A.I.dvisor tells us that WXIBF and WXXWY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WXIBF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
N/A
WXXWY - WXIBF
32%
Poorly correlated
+8.25%
IRON - WXIBF
28%
Poorly correlated
-0.03%
WHWK - WXIBF
24%
Poorly correlated
+1.98%
ELVAF - WXIBF
22%
Poorly correlated
N/A
KZR - WXIBF
20%
Poorly correlated
-0.50%
More